Home / Community / News / News

News

10/16/2018 - 8:19am

A new review looks at the cross-disease evidence for RAN translation’s contributions to pathogenesis.

09/25/2018 - 11:38am

Publication of a new systematic review provides insights into clinical outcome measures for DM2.

09/25/2018 - 11:30am

Induced pluripotential stem cells (iPSCs) from DM2 provide new tools for CNS-focused mechanistic and translational studies.

06/12/2018 - 7:23am

The RNA binding protein, rbFOX1, competes with MBNL in binding to CCUGexp, but not CUGexp repeats, and thereby mitigates DM2.

06/12/2018 - 7:13am

The review journal, Frontiers in Neurology, is publishing six new articles on myotonic dystrophy.

Partners

ExpansionTherapeutics.png

© Myotonic Dystrophy Foundation. All rights reserved.